Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects
-
Martin Hill
Abstract
17-Hydroxypregnenolone (3β, 17α-dihydroxypregn-5-en-20-one) and pregnenolone (3β-hydroxypregn-5-en-20-one) were determined by radioimmunoassay following HPLC separation in serum of healthy subjects of both sexes from 2 to 66 years old (29 girls, 85 women, 30 boys, 89 men). The effects of age and sex on the levels of both steroids were investigated and the upper limits of normal in age groups were determined.
The 17-hydroxypregnenolone levels as a function of age were characterized by a statistically significant maximum at the age of 18 and 20 years followed by a local minimum at the age of 39 and 37 years and by a statistically insignificant local maximum at the age of 55 and 49 years in men and women, respectively.
Pregnenolone age-dependence was similar and the statistically significant maximum was reached at the age of 17 and 16 years, the local minimum occurred at the age of 37 and 38 years and the second, statistically insignificant, local maximum at the age of 48 and 47 years in men and women, respectively.
Both 17-hydroxypregnenolone and pregnenolone in both sexes exhibited similarly shaped peaks with age. Both peaks of the polynomial fit in 17-hydroxypregnenolone were more pronounced in men than in women (13.0 and 9.20 nmol/l in the first peak; 7.72 and 4.78 in the second peak respectively). The situation with pregnenolone was the opposite. Both peaks of the polynomial fit in pregnenolone were lower in men than in women (2.29 and 3.21 nmol/l in the first peak; 0.92 and 1.78 in the second peak, respectively).
The higher serum levels of pregnenolone at puberty and during fertile age and their wider variance in comparison with men could, be explained by the different gonadal steroidogenesis depending on the menstrual cycle, where the pregnenolone serves as a substrate for progesterone formation.
The age dependencies of 17-hydroxypregnenolone and pregnenolone in women resembled that of unconjugated dehydroepiandrosterone. These results indicate that the increased metabolic activity in gonads in adolescence concerns not only dehydroepiandrosterone as the product of the 5-ene metabolic pathway but also its precursors.
Copyright (c)1999 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness
- Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review
- Improved Fluorescent PCR-Based Assay for Sizing CGG Repeats at the FRAXA Locus
- The Influence of Radiation and Chemotherapy-Related DNA Strand Breaks on Carcinogenesis: An Evaluation
- A Simple HPLC Method for Monitoring Mycophenolic Acid and Its Glucuronidated Metabolite in Transplant Recipients
- The Activities of Some Glycosaminoglycan-Degrading Enzymes in the Wall of the Umbilical Cord Artery and Their Alteration in Edema, Proteinuria, Hypertension (EPH)-Gestosis
- Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease
- Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease
- Biomarkers of Bone Turnover and Bone Mineral Density in Hyperprolactinemic Amenorrheic Women
- Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects
- A Study of Hypermagnesaemia in a Hospital Population
- Multiple Regression Analysis of Interference Effects from a Hemoglobin-Based Oxygen Carrier Solution
- Serum Ionized Magnesium: Comparison of Results Obtained with Three Ion-Selective Analyzers
- Automated Prozone Effect Detection in Ferritin Homogeneous Immunoassays Using Neural Network Classifiers
- Recent Activities of EC4 in the Harmonization of Clinical Chemistry in the European Union
- Preventing Coronary Artery Disease. Cardioprotective Therapeutics in Practice. Edited by M. J. Kendall and R. C. Horton
- Will Medical Schools Remain what They Are? Medical Education in the Millennium. Edited by Brian Jolly and Lesley Rees
Articles in the same Issue
- Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness
- Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review
- Improved Fluorescent PCR-Based Assay for Sizing CGG Repeats at the FRAXA Locus
- The Influence of Radiation and Chemotherapy-Related DNA Strand Breaks on Carcinogenesis: An Evaluation
- A Simple HPLC Method for Monitoring Mycophenolic Acid and Its Glucuronidated Metabolite in Transplant Recipients
- The Activities of Some Glycosaminoglycan-Degrading Enzymes in the Wall of the Umbilical Cord Artery and Their Alteration in Edema, Proteinuria, Hypertension (EPH)-Gestosis
- Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease
- Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease
- Biomarkers of Bone Turnover and Bone Mineral Density in Hyperprolactinemic Amenorrheic Women
- Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects
- A Study of Hypermagnesaemia in a Hospital Population
- Multiple Regression Analysis of Interference Effects from a Hemoglobin-Based Oxygen Carrier Solution
- Serum Ionized Magnesium: Comparison of Results Obtained with Three Ion-Selective Analyzers
- Automated Prozone Effect Detection in Ferritin Homogeneous Immunoassays Using Neural Network Classifiers
- Recent Activities of EC4 in the Harmonization of Clinical Chemistry in the European Union
- Preventing Coronary Artery Disease. Cardioprotective Therapeutics in Practice. Edited by M. J. Kendall and R. C. Horton
- Will Medical Schools Remain what They Are? Medical Education in the Millennium. Edited by Brian Jolly and Lesley Rees
